Instadose Pharma (INSD) Financial Statements
Instadose Pharma Financial Overview
Instadose Pharma's market cap is currently $53.19K. The company's EPS TTM is $-0.00; its P/E ratio is -0.02; Instadose Pharma has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Nov 21 | Nov 20 | Nov 19 | Nov 18 | Nov 17 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | ― | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | ― | $ 0.00 |
| Operating Income | $ -462.02K | $ -25.66K | $ -23.27K | $ -23.54K | $ -31.95K |
| EBITDA | $ -100.43K | $ -5.87K | $ -23.27K | ― | $ -31.95K |
| Net Income | $ -589.00K | $ -33.31K | $ -38.58K | ― | ― |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 0.00 | $ 84.00 | $ 84.00 | $ 133.00 | $ 1.40K |
| Total Assets | $ 3.00K | $ 84.00 | $ 84.00 | $ 133.00 | $ 1.40K |
| Total Debt | $ 0.00 | $ 0.00 | $ 55.66K | $ 32.73K | $ 11.90K |
| Net Debt | $ 0.00 | $ -84.00 | $ 55.58K | $ 32.60K | $ 10.50K |
| Total Liabilities | $ 127.02K | $ 206.80K | $ 107.02K | $ 44.52K | $ 16.88K |
| Stockholders' Equity | $ -127.02K | $ -106.94K | $ -97.52K | $ -44.38K | $ -15.48K |
| Cash Flow | |||||
| Free Cash Flow | $ -83.00 | $ -83.00 | $ 277.00 | $ -4.16K | $ -26.75K |
| Operating Cash Flow | $ -83.00 | $ -83.00 | $ 277.00 | $ -4.16K | $ -26.75K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 0.00 | $ 254.00 | $ 428.00 | $ 2.85K | $ 16.54K |
Currency in USD
